title: Pharmacokinetics of intravenous, intraperitoneal, and subcutaneous recombinant erythropoietin in patients on CAPD. A rationale for treatment.
authors.affiliation: KRUF Institute of Renal Disease, University of Wales College of Medicine, Royal Infirmary, Cardiff, UK.
authors.forename: I C
authors.initials: IC
authors.lastname: Macdougall
authors.forename: D E
authors.initials: DE
authors.lastname: Roberts
authors.forename: P
authors.initials: P
authors.lastname: Neubert
authors.forename: A D
authors.initials: AD
authors.lastname: Dharmasena
authors.forename: G A
authors.initials: GA
authors.lastname: Coles
authors.forename: J D
authors.initials: JD
authors.lastname: Williams
mesh_terms: D000328:Adult; D000368:Aged; D000740:Anemia / Q000150:complications / Q000188:drug therapy; D001682:Biological Availability; D002986:Clinical Trials as Topic; D004921:Erythropoietin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007674:Kidney Diseases / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory
chemical_list: D004921:Erythropoietin